| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2011 , Vol 53 , Num 1
FABRICATION AND IN VITRO EVALUATION OF GLIQUIDONE MATRIX TABLETS WITH ABELMOSCHUS ESCULENTUS FRUIT MUCILAGE AND POVIDONE COMBINATION
College of Pharmacy, Sri Krishnadevaraya University, Anantapur, Andhra Pradesh, India
Viewed :
18930
-
Downloaded :
6433
The main objective of the present study was to develop matrix tablets of Gliquidone with Abelmoschus esculentus fruit mucilage and Povidone and to study its functionality as a matrix forming agent for controlled release tablet formulations. Physicochemical properties of dried powdered mucilage of A. esculentus mucilage were studied. Various formulations containing Gliquidone, A. esculentus fruit mucilage and Povidone were prepared. The drug-excipient compatibility studies, physicochemical properties, pre compression and post compression properties were performed and satisfactory results were obtained. These results proved that the dried A. esculentus mucilage and Povidone combination can be used as a matrix forming material for making controlled release matrix tablets.
Keywords :
GLIQUIDONE, ABELMOSCHUS ESCULENTUS, POVIDONE, MATRIX TABLETS, CONTROLLED RELEASE